Full-Time

Director – Global Regulatory Affairs

Precision Medicine

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Risk & Compliance
Legal & Compliance
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree required; Advanced degree in life sciences, pharmacy, chemistry, or a related field (Ph.D., Pharm.D., or M.S.) preferred.
  • 10+ years of experience in regulatory affairs, with a strong focus on regulatory strategy for global drug development.
  • Proven track record of successful global regulatory submissions and approvals.
  • In-depth knowledge of global regulatory requirements and guidelines for both small molecule and biologics drug development.
  • Experience in radiopharmaceuticals and/or diagnostics drug products preferred.
  • Experience in leading and managing regulatory teams, with a demonstrated ability to mentor and develop staff.
  • Strong analytical, strategic thinking, and problem-solving skills.
  • Excellent communication and negotiation skills, with the ability to influence and build consensus across diverse teams.
  • Ability to work effectively in a fast-paced, dynamic environment with changing priorities.
  • Experience in regulatory interactions with global health authorities, including FDA and EMA.
  • Proven ability to manage multiple projects and priorities simultaneously.
Responsibilities
  • Lead the development and implementation of global regulatory strategies for small molecule products, from early development through commercialization.
  • Identify and mitigate regulatory risks, ensuring alignment with business objectives and timelines.
  • Provide strategic regulatory guidance to cross-functional teams, including R&D, clinical, manufacturing, and commercial teams.
  • Oversee the preparation, submission, and management of regulatory filings, including INDs, NDAs, BLAs, MAAs, and other global regulatory submissions.
  • Liaise with global health authorities, including the FDA, EMA, and other regulatory bodies, to facilitate product approvals.
  • Ensure timely responses to regulatory inquiries and oversee the negotiation of regulatory pathways.
  • Ensure that all regulatory activities are conducted in compliance with applicable laws, regulations, and guidelines.
  • Monitor the global regulatory environment, assess the impact of new regulations, and communicate changes to relevant stakeholders.
  • Develop and implement regulatory policies, procedures, and best practices.
  • Lead, mentor, and develop a high-performing global regulatory affairs team.
  • Foster a collaborative and innovative team culture, promoting professional growth and continuous learning.
  • Allocate resources effectively to meet project timelines and regulatory goals.
  • Collaborate with internal and external stakeholders, including clinical, manufacturing, legal, and commercial teams, to ensure regulatory alignment.
  • Represent regulatory affairs in senior management meetings and decision-making processes.
  • Build and maintain relationships with key regulatory agencies and external partners.
  • Provide regulatory due diligence and support for business development activities, including mergers and acquisitions, licensing, and partnership opportunities.
  • Assess regulatory risks and opportunities for potential new projects or acquisitions.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products for diagnosing and treating cancer and rare diseases using targeted radiation. Their products aim to enhance treatment decisions and offer personalized therapy for conditions that lack effective solutions. The company focuses on areas such as prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix has a global supply chain to manufacture and distribute its specialized products to healthcare providers and patients. Unlike many competitors, Telix emphasizes sustainability, patient care, and ethical practices in its operations. The goal of Telix Pharmaceuticals is to improve the quality of life for patients by providing advanced diagnostic and therapeutic options.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

19%

1 year growth

41%

2 year growth

105%
Simplify Jobs

Simplify's Take

What believers are saying

  • Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
  • Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
  • The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.

What critics are saying

  • The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
  • The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.

What makes Telix Pharmaceuticals unique

  • Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
  • The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
  • Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.

Help us improve and share your feedback! Did you find this helpful?